Pituitary-adrenocortical function in abdominal obesity of males: Evidence for decreased 21-Hydroxylase activity

Journal of Steroid Biochemistry and Molecular Biology

Volumn 58, Issue 1, 1996, Pages 123-133

  Hautanen, Aarno ^a   Adlercreutz, Herman ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTODOXONE; DEXAMETHASONE; HYDROCORTISONE; HYDROXYPROGESTERONE; PRASTERONE; STEROID 21 MONOOXYGENASE;

ADULT; ARTICLE; ENZYME ACTIVITY; HUMAN; HUMAN EXPERIMENT; HYPOPHYSIS ADRENAL SYSTEM; MALE; OBESITY;

EID: 0030130527     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(96)00013-1     Document Type: Article

References (30)

1. 1. Björntorp P.: Abdominal fat distribution and disease: an overview of epidemiological data. Ann. Med. 24 (1992) 15-18.
2. 2. Bouchard C., Despres J.-P. and Mauriege P.: Genetic and nongenetic determinants of regional fat distribution. Endocr. Rev. 14 (1993) 72-93.
3. 3. Björntorp P.: Metabolic implications of body fat distribution. Diabetes Care 14 (1991) 1132-1143.
4. 4. Glass A. R.: Endocrine aspects of obesity. Med. Clin. N. Amer. 73 (1989) 139-160.
5. 5. Strain G. W., Zumoff B., Strain J. J., Levin J. and Fukushima D. K.: Cortisol production in obesity. Metabolism 29 (1980) 980-985.
6. 6. Marin P., Darin N., Amemiya T., Andersson B., Jern S. and Björntorp P.: Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism 41 (1992) 882-886.
7. 7. Pasquali R., Cantobelli S., Casimirri F., Capelli M., Bortoluzzi L., Flamia R., Labate A. M. and Barbara L.: The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J. Clin. Endocrinol. Metab. 77 (1993) 341-346.
8. 8. Hautanen A. and Adlercreutz H.: Altered adrenocorticotropin and cortisol secretion in abdominal obesity: implications for the insulin resistance syndrome. J. Intern. Med. 234 (1993) 461-469.
9. 9. Williams D. P., Boyden T. W., Pamenter R. W., Lohman T. G. and Going S. B.: Relationship of body fat percentage and fat distribution with dehydroepiandrosterone sulfate in premenopausal females. J. Clin. Endocrinol. Metab. 77 (1993) 80-85.
10. 10. Khaw K.-T. and Barrett-Connor E.: Fasting plasma glucose levels and endogenous androgens in non-diabetic postmenopausal women. Clin. Sci. 80 (1991) 199-203.
11. 4-androstenedione and dehydroepiandrosterone in simple obesity despite increased metabolic clearance rates: evidence for a servo-control mechanism. J. Clin. Endocrinol. Metab. 64 (1987) 1261-1267.
12. 12. Vermeulen A., Kaufman J. M., Deslypere J. P. and Thomas G.: Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men. J. Clin. Endocrinol. Metab. 76 (1993) 1140-1146.
13. 13. Hautanen A., Sarna S., Pelkonen R. and Adlercreutz H.: Serum sex-hormone binding globulin, cardiovascular risk factors and adrenal cortisol responses to dexamethasone and corticotropin. Metabolism 42 (1993) 870-874.
14. 14. Hautanen A. and Adlercreutz H.: Hyperinsulinaemia, dyslipidaemia and exaggerated adrenal androgen response to adrenocorticotropin in male smokers. Diabetologia 36 (1993) 1275-1281.
15. 15. Hypertension Detection and Follow-up Program Cooperative Group: Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. J. A. M. A. 242 (1979) 2562-2571.
16. 16. World Health Organization: Diabetes Mellitus; Report of a WHO Study Group. Tech. Rep. Ser. No. 727 (1985) World Health Org., Geneva.
17. 17. New M. I., White P. C., Pang S., Dupont B. and Speiser P. W.: The adrenal hyperplasias. In The Metabolic Basis of Inherited Diseases (Edited by C. R. Scriver, A. L. Beaudet, W. S. Sly and D. Valle). McGraw-Hill, New York, Vol. 2 (1989) pp. 1881-1917.
18. 18. Miller W. L.: Genetics, diagnosis, and management of 21-hydroxylase deficiency. J. Clin. Endocr. Metab. 78 (1994) 241-246.
19. 19. Landon J., James V. H., Wharton M. J. and Friedman M.: Threshold adrenocortical sensitivity in man and its possible application to corticotrophin bioassay. Lancet 2 (1967) 697-700.
20. 20. Hautanen A., Mänttäri M., Kupari M., Manninen V., Frick M. H. and Adlercreutz H.: Cigarette smoking is associated with elevated adrenal androgen responses to adrenocorticotropin. J. Steroid Biochem. Molec. Biol. 46 (1993) 245-251.
21. 21. Yeh J. and Barbieri R. L.: Effects of smoking on steroid production, metabolism, and estrogen-related disease. Semin. Repr. Endocrinol. 7 (1989) 326-334.
22. 22. Dunkelman S. S., Fairhurst B., Plager J. and Waterhouse C.: Cortisol metabolism in obesity. J. Clin. Endocrinol. 24 (1964) 832-841.
23. 23. Streeten D. H. P., Stevenson C. T., Dalakos T. G., Nicholas J. J., Dennick L. G. and Fellerman H.: The diagnosis of hypercortisolism. Biochemical criteria differentiating patients from lean and obese normal subjects and from females on oral contraceptives. J. Clin. Endocrinol. Metab. 29 (1969) 1191-1211.
24. 24. Rebuffe-Scrive M., Brönnegard M., Nilsson A., Eldh J., Gustafsson J.-Å. and Björntorp P.: Steroid hormone receptors in human adipose tissues. J. Clin. Endocrinol. Metab. 71 (1990) 1215-1219.
25. 25. Reaven G.: Treatment of hypertension: focus on prevention of coronary heart disease. J. Clin. Endocrinol. Metab. 76 (1993) 537-740.
26. 26. Nestler J. E., McClanahan M. A., Clore J. N. and Blackard W. G.: Insulin inhibits adrenal 17,20-lyase activity in man. J. Clin. Endocrinol. Metab. 74 (1992) 362-367.
27. 27. Lacroix A., Bolte E., Tremblay J., Dupre J., Poitras P., Fournier H., Garon J., Garrel D., Bayrad F. and Taillefer R.: Gastric inhibitory polypeptide-dependent cortisol hypersecretion - a new cause of Cushing's syndrome. N. Engl. J. Med. 327 (1992) 974-980.
28. 28. Reznik Y., Allali-Zerah V., Chayvialle J. A., Leroyer R., Leymarie P., Travert G., Lebrethon M. C., Budi I., Balliere A. M. and Mahoudeau J.: Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N. Engl. J. Med. 327 (1992) 981-986.
29. 29. New M. I., Lorenzen F., Lerner A. J., Kohn B., Oberfield S. E., Pollack M. S., Dupont B., Stoner E., Levy D. J., Pang S. and Levine L. S.: Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J. Clin. Endocrinol. Metab. 57 (1983) 320-326.
30. 30. Speiser P. W., Serrat J., New M. I. and Gertner J. M.: Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 75 (1992) 1421-1424.